The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
Clinical trial NCT06597526 · RECRUITING
Trial details
- NCT number
- NCT06597526
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-15
- Primary completion
- 2028-03-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.